These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9623556)

  • 21. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
    Pol S; Thiers V; Carnot F; Zins B; Roméo R; Berthelot P; Bréchot C
    Nephrol Dial Transplant; 1996; 11 Suppl 4():58-61. PubMed ID: 8918758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Distribution of hepatitis C virus genotypes among the hemodialysis population in the province of Alicante].
    Arenas MD; Muñoz C; Sánchez-Payá J; Jover R; Egea JJ; Gil MT; Martín F; Sarró F; Soriano A; Luna A; Olivares J; Reyes A; Muñoz del Bustillo E; del Pozo C; Valverde V; Perdiguero M; Araque A
    Nefrologia; 2001; 21(6):581-7. PubMed ID: 11881428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus.
    Imhof M; Popal H; Lee JH; Zeuzem S; Milbradt R
    Dermatology; 1997; 195(1):1-5. PubMed ID: 9267728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
    Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
    Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viraemia, cryoglobulins and autoantibodies in haemodialysis patients infected with hepatitis C virus.
    Siagris D; Labropoulou-Karatza C; Christofidou M; Goumenos D; Thomopoulos K; Lekkou A; Gogos CA; Vlachojannis J
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):133-7. PubMed ID: 12560756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
    Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
    Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of DNA sequence hybridization with specific oligonucleotide probes to identify hepatitis C virus genotypes].
    Domingo MJ; Fernández I; Lumbreras C; Manzanares J; Morales JM; Noriega AR; Fuertes A
    Enferm Infecc Microbiol Clin; 1996; 14(7):433-5. PubMed ID: 8991438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus mixed genotype infection in patients on haemodialysis.
    Qian KP; Natov SN; Pereira BJ; Lau JY
    J Viral Hepat; 2000 Mar; 7(2):153-60. PubMed ID: 10760046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients.
    Colleoni N; Bucci R; Ribero ML; Zhou J; D'Amico G; Tagger A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2258-64. PubMed ID: 8941587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for HCV infection in two haemodialysis units in The Netherlands.
    Keur I; Schneeberger PM; van der Graaf Y; Vos J; van Dijk WC; van Doorn LJ
    Neth J Med; 1997 Mar; 50(3):97-101. PubMed ID: 9121598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
    Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T
    Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective virological follow-up of hepatitis C infection in a haemodialysis unit.
    Halfon P; Khiri H; Feryn JM; Sayada C; Chanas M; Ouzan D
    J Viral Hepat; 1998 Mar; 5(2):115-21. PubMed ID: 9572036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis.
    Zitha T; Chen CY; Mudawi H; Hussein W; Mukhtar M; Shigidi M; Yousif MEA; Ali MA; Glebe D; Kramvis A
    BMC Infect Dis; 2022 Nov; 22(1):848. PubMed ID: 36376846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.